Isolevuglandin-Modified Cardiac Proteins Drive CD4+ T Cell Activation in the Heart and Promote Cardiac Dysfunction.
暂无分享,去创建一个
D. Harrison | M. Aronovitz | V. Amarnath | Annet Kirabo | Robert M. Blanton | Ane M. Salvador | T. Nevers | Francisco E. Velázquez | P. Alcaide | A. Tai | Njabulo Ngwenyama | F. Carrillo-Salinas
[1] E. K. Weir,et al. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling. , 2019, Free radical biology & medicine.
[2] K. Kaur,et al. Heart Inflammation: Immune Cell Roles and Roads to the Heart. , 2019, The American journal of pathology.
[3] M. Aronovitz,et al. Distinct Phenotypes Induced by Three Degrees of Transverse Aortic Constriction in Mice , 2019, Scientific Reports.
[4] M. Aronovitz,et al. CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction. , 2019, JCI insight.
[5] S. Prabhu,et al. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice , 2019, Redox biology.
[6] Annet Kirabo,et al. Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension. , 2018, Prostaglandins & other lipid mediators.
[7] Sumanth D. Prabhu,et al. CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload , 2018, JACC. Basic to translational science.
[8] G. Hasenfuss,et al. T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure , 2017, Scientific Reports.
[9] M. Aronovitz,et al. Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure , 2017, The Journal of experimental medicine.
[10] Huan Wang,et al. Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy , 2017, Basic Research in Cardiology.
[11] Xin Xu,et al. CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs , 2016, Hypertension.
[12] V. Víctor,et al. Role of ROS and RNS Sources in Physiological and Pathological Conditions , 2016, Oxidative medicine and cellular longevity.
[13] G. Dubyak,et al. T cell–intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis , 2016, Nature Immunology.
[14] R. Karas,et al. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload–Induced Heart Failure , 2016, Journal of the American Heart Association.
[15] R. Karas,et al. Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure , 2015, Circulation. Heart failure.
[16] D. Mann,et al. Role of innate and adaptive immune mechanisms in cardiac injury and repair , 2015, Nature Reviews Immunology.
[17] D. Harrison,et al. DC isoketal-modified proteins activate T cells and promote hypertension. , 2014, The Journal of clinical investigation.
[18] C. Vinel,et al. CD4+ T Cells Promote the Transition From Hypertrophy to Heart Failure During Chronic Pressure Overload , 2014, Circulation.
[19] O. Nureki,et al. Toll‐Like Receptor‐2 Mediates Adaptive Cardiac Hypertrophy in Response to Pressure Overload Through Interleukin‐1β Upregulation via Nuclear Factor κB Activation , 2013, Journal of the American Heart Association.
[20] C. Albert,et al. Vitamin E Supplementation and the Risk of Heart Failure in Women , 2012, Circulation. Heart failure.
[21] Nicole R. Cunningham,et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse , 2011, The Journal of experimental medicine.
[22] D. Kass,et al. Role of oxidative stress in cardiac hypertrophy and remodeling. , 2007, Hypertension.
[23] D. Kass,et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.
[24] S. Yusuf,et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.
[25] Ciriana Orabona,et al. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86 , 2004, Nature Immunology.
[26] Masahiro Ito,et al. Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox , 2004, Circulation.
[27] A. Shah,et al. Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy , 2003, Circulation research.
[28] E. Topol,et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.
[29] M. Hori,et al. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. , 2002, Journal of the American College of Cardiology.
[30] D. Harrison,et al. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. , 2016, The Journal of clinical investigation.
[31] S. Davies. Modulation of protein function by isoketals and levuglandins. , 2008, Sub-cellular biochemistry.